文献速递神经核医学肿瘤 PET/CT

边缘为主型年龄相关TDP-43脑病与阿尔茨海默病的共病理:[18F]FDG PET统计映射与定量MRI体积分析

Copathologies of Limbic-Predominant Age-Related TDP-43 Encephalopathy and Alzheimer Disease: [18F]FDG PET Statistical Mapping and Quantitative MRI Volumetry.
PubMed 文献 · J Nucl Med · 2026-04-01

该回顾性研究分析了944例来自认知障碍门诊的[18F]FDG PET病例,利用尸检证实的LATE和AD病例构建三维立体定向表面投影PET模板,将患者分为可能LATE、LATE+AD和可能AD组。结果显示13.0%为可能LATE(2.4%纯LATE,10.6% LATE+AD),23.7%为可能AD无LATE;纯LATE以内侧颞叶萎缩最著,混合LATE+AD以眶额回和外侧颞叶最易受累,且LATE+AD组约四分之三病例呈现左侧优势的代谢改变和萎缩。

要点

  • 尸检证实的LATE和AD PET模板可客观识别临床可能的LATE特征。
  • 纯LATE以内侧颞叶萎缩为主,混合LATE+AD以眶额回和外侧颞叶受累为主。
  • LATE+AD共病理显示左侧优势的协同代谢和萎缩改变。

核心结论

  • 相当比例认知障碍患者存在LATE特征,可用尸检证实病例的PET模板客观识别。
  • LATE病例与定量MRI上特定区域萎缩相关,LATE+AD共病理呈现协同性半球受累。

研究设计与样本

  • 回顾性分析944例三级中心认知障碍门诊转诊的[18F]FDG PET病例。
  • 利用尸检证实的LATE(n=6)和AD(n=32)病例构建三维立体定向表面投影PET模板。
  • 以20例淀粉样PET阴性对照的正常PET扫描生成z评分图。
  • 根据尸检来源z评分图计算z评分乘积指数,将受试者分为可能LATE、LATE+AD和可能AD。
  • 采用单因素或Welch ANOVA及Fisher精确检验比较临床和定量MRI体积数据。

主要发现

  • 944例临床病例中13.0%为可能LATE(2.4%纯LATE,10.6% LATE+AD),23.7%为可能AD无LATE。
  • MRI体积分析显示纯LATE以内侧颞叶受累最著(P < 0.001)。
  • 混合LATE+AD以眶额回和外侧颞叶最易受累(P = 0.001;P < 0.001)。
  • 内嗅皮层和杏仁核分别是区分混合LATE+AD与纯LATE、纯AD的关键区域(P = 0.05;P < 0.001)。
  • 可能LATE+AD亚组中约四分之三病例基于LATE和AD z评分乘积呈现一致的左侧优势代谢改变(P < 0.001),MRI体积亦见类似左侧优势萎缩模式。

关键数值与推荐

  • 可能LATE定义为z评分乘积指数符合LATE模板特征,包括纯LATE和LATE+AD。
  • 纯LATE以内侧颞叶萎缩为最著(P < 0.001)。
  • 混合LATE+AD以眶额回(P = 0.001)和外侧颞叶(P < 0.001)萎缩为最著。
  • 内嗅皮层区分混合LATE+AD与纯LATE(P = 0.05),杏仁核区分混合LATE+AD与纯AD(P < 0.001)。

临床怎么用

  • 可利用尸检证实的LATE和AD PET模板及z评分乘积指数,在[18F]FDG PET上辅助识别可能LATE及其与AD的共病理。
  • 定量MRI体积分析中内侧颞叶萎缩提示纯LATE,眶额回和外侧颞叶萎缩提示混合LATE+AD。
  • LATE+AD共病理病例需注意左侧优势的代谢和萎缩改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Limbic-predominant age-related transactive response DNA-binding protein 43 kDa encephalopathy (LATE) is emerging as a prevalent neurodegenerative disorder in aging populations, mimicking the clinical presentation of Alzheimer disease (AD). This study investigates in vivo [18F]FDG PET and MRI biomarkers in detecting probable LATE neuropathologic change. Methods: We retrospectively analyzed 944 [18F]FDG PET cases referred from cognitive disorder clinics in a tertiary care center. To characterize the LATE and AD findings objectively and quantitatively, we created 3-dimensional stereotactic surface projection PET templates for LATE neuropathologic change (n = 6) and AD neuropathologic change (n = 32) from autopsy-confirmed Alzheimer's Disease Neuroimaging Initiative and University of Utah datasets, respectively. All 3-dimensional stereotactic surface projection z score [18F]FDG maps were created in comparison to normal PET scans from 20 control cases whose amyloid PET scans were negative. Using the autopsy-derived z score maps, z score product indices (the individual z score map multiplied by the z scores of autopsy-confirmed cohorts) were generated for each subject, stratifying participants into probable LATE, probable LATE and AD (LATE+AD), and probable AD. Clinical and quantitative MRI volumetry data were compared across the groups using 1-way or Welch ANOVA and Fisher exact tests, depending on the assessed variables. Results: Of the 944 clinical cases, 13.0% were characterized as probable LATE (2.4% pure LATE and 10.6% LATE+AD) and 23.7% were characterized as probable AD without LATE. MRI volumetry revealed that the medial temporal lobe was most affected in pure LATE cases (P < 0.001), whereas the orbitofrontal gyrus and lateral temporal lobe were most vulnerable in mixed LATE+AD cases (P = 0.001; P < 0.001). Post hoc analysis identified the entorhinal cortex and amygdala as key regions for distinguishing mixed LATE+AD cases from pure LATE and pure AD cases, respectively (P = 0.05; P < 0.001). Subgroup analysis of the probable LATE+AD group demonstrated additive or synergistic effects of both pathologies, with three quarters of cases exhibiting concordant lateralized metabolic brain changes, predominantly left-sided, based on LATE and AD z score products (P < 0.001). A similar pattern of left-dominant brain atrophy was observed in MRI volumetry. Conclusion: Substantial numbers of our patients exhibited LATE features that were characterized objectively using scans from autopsy-proven cases. These LATE cases were associated with specific regional atrophy measured by quantitative MRI. Cases with LATE+AD copathologies demonstrated synergistic hemispheric involvement. Further investigations of such synergistic changes between LATE and AD are warranted.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ngam PI, Anzai Y, Cliatt Brown CJ, et al. Copathologies of Limbic-Predominant Age-Related TDP-43 Encephalopathy and Alzheimer Disease: [18F]FDG PET Statistical Mapping and Quantitative MRI Volumetry. J Nucl Med. 2026. PMID: 41571430. doi:10.2967/jnumed.125.270614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。